Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Filip, Vrbacky"'
Autor:
Laura Ondrisova, Vaclav Seda, Eva Hoferkova, Giorgia Chiodin, Krystof Hlavac, Lenka Kostalova, Daniel Filip, Pedro Faria Zeni, Anna Panovska, Karla Plevova, Sarka Pospisilova, Martin Simkovic, Filip Vrbacky, Daniel Lysak, Stacey M. Fernandes, Matthew S. Davids, Alba Maiques-Diaz, Stella Charalampopoulou, Jose I Martin-Subero, Jennifer R Brown, Michael Doubek, Francesco Forconi, Jiri Mayer, Marek Mraz
Publikováno v:
HemaSphere, Vol 7, p e8228434 (2023)
Externí odkaz:
https://doaj.org/article/d170c389beac401f8b76921cc6daacb9
Autor:
Alessandro Campanella, Antonella Capasso, Caterina Taccetti, Silvia Heltai, Elisa Albi, Yair Herishanu, Sabine Haggenburg, Thomas Chatzikonstantinou, Michael Doubek, Magdalena Kättström, Krzysztof Giannopoulos, Martin Simkovic, Carol Moreno, Massimo Massaia, Horia Bumbea, Salem Al Shimmari, Pamela Ranghetti, Eleonora Perotta, Francesca Martini, Emanuela Sant’antonio, Maria Colia, Catalina Combi, Shai Levi, Arnon Kater, Mette Hazenberg, Inger Nijhof, Quincy Hofsink, Christos Demosthenous, Jana Kotaskova, Joanna Zaleska, Filip Vrbacky, Alba Mora, Davide Bisogno, Ignazio Ezio Tripoli, Viola Maria Popov, Viviana Roman, Eloise Scarano, Michela Frenquelli, Lydia Scarfò, Kostas Stamatopoulos, Paolo Ghia
Publikováno v:
HemaSphere, Vol 7, p e483427a (2023)
Externí odkaz:
https://doaj.org/article/95dec98f89594135be22f30c2711ec0e
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 5, Pp 533-538 (2022)
Background: Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is still a very dangerous and life-threatening disease with an extremely heterogeneous course. Older patients and those with comorbidities are at increased risk of death f
Externí odkaz:
https://doaj.org/article/1d85954f82f44f3398b60b210ac9365d
Autor:
Petra Belohlavkova, Filip Vrbacky, Jaroslava Voglova, Zdenek Racil, Daniela Zackova, Katerina Hrochova, Jana Malakova, Jiri Mayer, Pavel Zak
Publikováno v:
Archives of Medical Science, Vol 14, Iss 6, Pp 1416-1423 (2018)
Externí odkaz:
https://doaj.org/article/602ee88bf1304c86809033b0d80e72f9
Autor:
Monika Jaruskova, Nikola Curik, Rajna Hercog, Vaclava Polivkova, Eliska Motlova, Vladimir Benes, Hana Klamova, Pavla Pecherkova, Petra Belohlavkova, Filip Vrbacky, Katerina Machova Polakova
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-17 (2017)
Abstract Background Through high-throughput next-generation sequencing of promoters of solute carrier and ATP-binding cassette genes, which encode drug transporters, we aimed to identify SNPs associated with the response to imatinib administered for
Externí odkaz:
https://doaj.org/article/50d802bfd6834c5e9b0ebd9a761a70af
Autor:
Vladimir Palicka, Marcela Chmelarova, Sedláková I, Jan Laco, Filip Vrbacky, Petr Hejna, Helena Kovarikova, Dalibor Kovarik, Ivana Baranova
Publikováno v:
Clinical Chemistry and Laboratory Medicine (CCLM). 58:1332-1340
Background The lack of effective biomarkers for the screening and early detection of ovarian cancer (OC) is one of the most pressing problems in oncogynecology. Because epigenetic alterations occur early in the cancer development, they provide great
Publikováno v:
Journal of infection and public health. 15(5)
Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is still a very dangerous and life-threatening disease with an extremely heterogeneous course. Older patients and those with comorbidities are at increased risk of death from the dise
Autor:
Marian Kacerovsky, Filip Vrbacky, Radka Kutova, Lenka Pliskova, Ctirad Andrys, Ivana Musilova, Ramkumar Menon, Ronald Lamont, Jana Nekvindova
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0126884 (2015)
To analyze the cervical microbiota in women with preterm prelabor rupture of membranes (PPROM) by pyrosequencing and to document associations between cervical microbiota, cervical inflammatory response, microbial invasion of the amniotic cavity (MIAC
Externí odkaz:
https://doaj.org/article/3722fc6c6097469e935a047cf1ecaa7c
Autor:
Edgar Faber, Eduard Cmunt, Jaroslava Voglová, Michal Karas, Peter Rohon, Pavel Zak, Zlatuse Kristkova, Karel Indrak, Katerina Steinerova, Marek Trneny, Tomas Papajik, Filip Vrbacky, Tereza Nečasová, I. Skoumalová, Petra Belohlavkova
Publikováno v:
Leukemia Research. 81:67-74
We retrospectively evaluated the role of age and dosage in 372 CML patients (170 women, 202 men) treated with first-line imatinib (IMA) from the records of the CAMELIA registry. The median follow-up of the patients was 82.3 (18.0-177.3) months. The t
Publikováno v:
Clinical Biochemistry. 61:34-39
Objectives Molecular screening plays a major role in prognostic categorization and subsequent definition of treatment strategies for acute myeloid leukemia. The possibility of using IDH1/2 mutations as a marker for the monitoring of minimal residual